CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 81 enrolled
Drug / intervention
Alteplase +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02159521
NCT02159521Phase 4Completed
CompareCT.gov

ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System

Boston Scientific Corporation·interventional·Posted Jun 10, 2014·Updated Jul 19, 2021

In Brief

A Phase 4 clinical trial evaluating EkoSonic® Endovascular System and Alteplase for Deep Vein Thrombosis and Post-thrombotic Syndrome. Completed, enrolled 81 participants across 22 sites.

Detailed Summary

To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome from chronic venous occlusion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeep Vein Thrombosis, Post-thrombotic Syndrome
CountriesUnited States
CollaboratorsEKOS Corporation

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 10, 2014
Enrollment StartJul 10, 2014
Primary CompletionNov 30, 2017
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.1 years ago

Interventions

EkoSonic® Endovascular Systemdevice

Alteplasebiological

Recombinant tissue plasminogen activator